Cargando…
THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548795/ http://dx.doi.org/10.1016/j.chest.2020.09.048 |
_version_ | 1783592693005287424 |
---|---|
author | Trelles Garcia, Daniela Trelles Garcia, Valeria Rodriguez-Nava, Guillermo Yanez-Bello, Maria Bustamante-Soliz, Daniel Patino, Elizabeth Chung, Chul Won Friedman, Harvey |
author_facet | Trelles Garcia, Daniela Trelles Garcia, Valeria Rodriguez-Nava, Guillermo Yanez-Bello, Maria Bustamante-Soliz, Daniel Patino, Elizabeth Chung, Chul Won Friedman, Harvey |
author_sort | Trelles Garcia, Daniela |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7548795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American College of Chest Physicians. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75487952020-10-13 THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19 Trelles Garcia, Daniela Trelles Garcia, Valeria Rodriguez-Nava, Guillermo Yanez-Bello, Maria Bustamante-Soliz, Daniel Patino, Elizabeth Chung, Chul Won Friedman, Harvey Chest Late-breaking Abstract American College of Chest Physicians. Published by Elsevier Inc. 2020-10 2020-10-12 /pmc/articles/PMC7548795/ http://dx.doi.org/10.1016/j.chest.2020.09.048 Text en Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Late-breaking Abstract Trelles Garcia, Daniela Trelles Garcia, Valeria Rodriguez-Nava, Guillermo Yanez-Bello, Maria Bustamante-Soliz, Daniel Patino, Elizabeth Chung, Chul Won Friedman, Harvey THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19 |
title | THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19 |
title_full | THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19 |
title_fullStr | THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19 |
title_full_unstemmed | THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19 |
title_short | THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19 |
title_sort | anti-infective and immunomodulator paradox: increased risk of coinfection with hydroxychloroquine in critical patients with covid-19 |
topic | Late-breaking Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548795/ http://dx.doi.org/10.1016/j.chest.2020.09.048 |
work_keys_str_mv | AT trellesgarciadaniela theantiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT trellesgarciavaleria theantiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT rodrigueznavaguillermo theantiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT yanezbellomaria theantiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT bustamantesolizdaniel theantiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT patinoelizabeth theantiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT chungchulwon theantiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT friedmanharvey theantiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT trellesgarciadaniela antiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT trellesgarciavaleria antiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT rodrigueznavaguillermo antiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT yanezbellomaria antiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT bustamantesolizdaniel antiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT patinoelizabeth antiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT chungchulwon antiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 AT friedmanharvey antiinfectiveandimmunomodulatorparadoxincreasedriskofcoinfectionwithhydroxychloroquineincriticalpatientswithcovid19 |